Sponsor or institution

Clinical trials and research at InSilico Medicine Hong Kong Limited

• 7Clinical trials
• 3Countries

Newest trials

All recruiting trials (7)

• Rentosertib by mouth for people with idiopathic pulmonary fibrosis

  This is a randomized, placebo-controlled test to see if Rentosertib helps adults with idiopathic pulmonary fibrosis when taken as a pill.

  Recruiting at 12 sites Phase 3 InSilico Medicine Hong Kong Limited · Hefei, Anhui and 46 other locations · NCT07687459

• IS M8969 safety and PK/PD in healthy and at-risk adults

  This early-phase study tests ISM8969 versus placebo to see if it is safe, well tolerated, and how the body handles and responds to it in healthy adults and obese adults at risk for heart disease.

  Recruiting Phase 1 InSilico Medicine Hong Kong Limited · Melbourne, Victoria · NCT07581431

• Oral ISM5411 for adults with active ulcerative colitis (BETHESDA)

  This trial will test whether taking oral ISM5411 is safe and helps adults with active ulcerative colitis.

  Recruiting at 28 sites Phase 2 InSilico Medicine Hong Kong Limited · Beijing, Beijing Municipality and 27 other locations · NCT07265570

• Evaluating ISM6331 for advanced malignant mesothelioma and solid tumors

  This study is testing a new drug called ISM6331 to see if it is safe and effective for people with advanced malignant mesothelioma and other solid tumors who haven't had success with standard treatments.

  Recruiting at 10 sites Phase 1/2 InSilico Medicine Hong Kong Limited · Denver, Colorado and 9 other locations · NCT06566079

• Evaluating ISM8207 for advanced solid tumors and B-cell lymphoma

  This study is testing a new oral medication called ISM8207 to see if it is safe and helps people with advanced solid tumors and B-cell lymphoma that haven't responded to other treatments.

  Recruiting at 4 sites Phase 1 InSilico Medicine Hong Kong Limited · Beijing, Beijing Municipality and 3 other locations · NCT06445517

• Testing ISM3412 for advanced solid tumors with specific genetic markers

  This study is testing a new drug called ISM3412 to see if it can help people with advanced solid tumors that have specific genetic markers and who haven't had success with other treatments.

  Recruiting at 10 sites Phase 1/2 InSilico Medicine Hong Kong Limited · Denver, Colorado and 9 other locations · NCT06414460

• Evaluating INS018_055 for Idiopathic Pulmonary Fibrosis

  This study is testing a new oral medication called INS018_055 to see if it is safe and helps adults with Idiopathic Pulmonary Fibrosis feel better.

  Recruiting at 12 sites Phase 2 InSilico Medicine Hong Kong Limited · Birmingham, Alabama and 11 other locations · NCT05975983

Quick answers

How many clinical trials run by InSilico Medicine Hong Kong Limited are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in China (5 trials), United States (3 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 2: 2, Phase 1/2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →